|
Concordance between 21-gene score (Oncotype DX) and clinical-pathologic prognostic models in early-breast cancer in Medellín, Colombia. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Astellas Pharma; Bristol-Myers Squibb; MSD; Novartis |
Consulting or Advisory Role - MSD |
Speakers' Bureau - Astellas Pharma |
Research Funding - MSD (Inst) |
Travel, Accommodations, Expenses - Abbott; Astellas Pharma; Pfizer; Tecnofarma |
|
|
Travel, Accommodations, Expenses - Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |